LVCLY fundamentals
An in-depth look to ALGORAE PHARMACEUTICALS LTD. operating, investing, and financing activities
LVCLY free cash flow for H1 24 is -658.08 k USD. For 2023, LVCLY free cash flow was -1.34 M USD and operating cash flow was -1.34 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM